Events
For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide
We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forward.
PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector.
How To Meet Us
We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.
Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:
Upcoming events
28 February 2023
4th Annual European HealthTech CEO Forum
Asif Shahinsha will be taking part in panel discussions.
1-2 March 2023
16th Annual European Life Sciences CEO Forum
PharmaVentures will chair the Pharma Dealmakers Roundtable.
20-22 March and 28-30 March 2023
BIO-Europe Spring®
PharmaVentures’ team are taking part in 1-1 meetings online and in-person.
20-23 March 2023
DCAT Week
Dr Jansen Jacob, Vice President, will be in New York for 1-1 meetings.
Recent events
9-12 January 2023
BIO One-on-One Partnering™ During JPM Week
PharmaVentures’ team took part in 1-1 meetings.
9-11 January 2023
Biotech Showcase™
PharmaVentures’ team attended 1-1 meetings.
5-8 December 2022
Genesis 2022
Ralph Huges presented Trends in Early Stage Deals: Pricing and Market Access and the team took part in 1-1 meetings.
14-17 November 2022
MEDICA
Asif Shahinsha and Andreas Katsiamides took part in 1-1 meetings.
1-3 November 2022
CPhI Worldwide
Dr Fintan Walton, CEO, chaired the panel discussion: Transactional Strategies to Access Future Therapeutics and Technologies which included Abbvie, Medicxi, Thermo Fisher and PharmaVentures VP, Jansen Jacob.
24-26 October 2022
BIO-Europe®
PharmaVentures’ team took part in 1-1 meetings.
4-5 October 2022
Biopharm America
Jessie You took part in 1-1 meetings.
27 September 2022
BioForward
Enrique Bendito Moll took part in 1-1 meetings.
21-22 September 2022
22nd Annual Biotech in Europe Forum
Dr Fintan Walton, CEO, chaired the Global Pharma-Biotech Partnering and M&A Roundtable.
20 September 2022
9th Annual HealthTech Investment Forum
Asif Shahinsha took part in the Early Stage Investment panel discussion.
13-16 June 2022
BIO 2022
PharmaVentures took part in 1-1 meetings.
26-27 April 2022
BioTrinity 2022
Fotis Galiotis, Business Analyst, took part in 1-1 meetings.
28-31 March 2022
BIO-Europe Spring
Jessie You, Associate, took part in 1-1 meetings.
22-23 March 2022
5th Annual Neuroscience Innovation Forum
Jessie You took part in 1-1 meetings.
21-24 March 2022
DCAT Week
Jansen Jacob, Vice President, took part in 1-1 meetings.
9 March 2022
N-Site Expert Advice Clinic
Adrian Dawkes, Managing Director, took part in 1-1 meetings.
1-2 March 2022
15th Annual European Life Science CEO Forum
Dr Fintan Walton, CEO, chaired the Pharma M&A and Partnering Panel and Jessie You took part in 1-1 meetings.
28 February 2022
3rd Annual European HealthTech CEO Forum
Jessie You took part in 1-1 meetings and Mark Andrews took part in the Innovation and Early Stage Investment panel.
PharmaVentures InSights:
The impact of conference cancellations on dealmaking
during the Covid-19 pandemic
Can Partnering Conference Cancellations Affect Dealmaking in 2020?
We all got used to the partnering conference circuit as a means to introduce the latest developments to potential partners. So now they are all temporarily suspended whilst we overcome the current global health challenge, how do you make sure your opportunities are still getting in front of your potential partners.
PharmaVentures has been successfully connecting buyers and sellers for over 29 years with and without partnering conferences.
PharmaVentures’ CEO, Dr. Fintan Walton talks about how PharmaVentures is continuing a business as usual approach for all of our clients.
Don’t hesitate to contact us to help you carry on dealmaking.